Pharmacokinetic/Pharmacodynamic Equivalence of MSB11455 in Healthy Subjects

A Randomized, Double-blind, Crossover Study to Compare the Pharmacokinetic and Pharmacodynamic Bioequivalence of a Single Injection of MSB11455 and Neulasta in Healthy Adult Subjects

The purpose of the study is to compare the pharmacokinetics (PK) and pharmacodynamics (PD) of MSB11455 and Neulasta in healthy adult subjects.

Inclusion Criteria:

• Subjects who provide signed and dated written informed consent
• Other protocol defined inclusion criteria could apply

Exclusion Criteria:

• Subjects who have no known hypersensitivity to any component of Neulasta or MSB11455, and laboratory test results within predefined ranges
• Other protocol defined exclusion criteria could apply.